Legal advice for the placing was provided by a team led by Philip Wild, partner at Kidd Rapinet. They advised on the admission document, and established the share structure for the various rounds of funding.

DXS International’s trading subsidiary, DXS (UK) provides a software package that gives up-to-date information to doctors, nurses and pharmacists about medical conditions, as well as currently available treatments, drugs, hospital and treatment centre facilities and capabilities.

The DXS service solution is installed at 20,000 GP practices, 14,000 retail pharmacies and in hospitals, where it is integrated into electronic patient record systems, enabling doctors to view the latest research relating to an individual patient’s medical condition, available treatments, and view the different drugs available, all during the patient encounter.